Dev Kantesaria: Venture Investing In BiotechJacob Wolinsky
ValueWalk's Raul Panganiban interviews Dev Kantesaria, the Managing Partner at Valley Forge Capital Management. In this part, Dev discusses his background and what led him to investing, venture investing in biotech, how his experience has carried over to his current investment thinking and process, his long biased equity strategy, the importance of temperament for a successful public equity investor, business quality, his stock selection process, understanding the dynamics of a particular company or industry, the value in the present low interest rate environment, and if he considers himself a generalist.
exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible